Introduction: Breast cancer is one of the most common types of cancer in the world and the treatments are being improved day by day. Although chemotherapy agents have begun to be used, side effects, resistance develop...Introduction: Breast cancer is one of the most common types of cancer in the world and the treatments are being improved day by day. Although chemotherapy agents have begun to be used, side effects, resistance development and toxicity seen with these drugs are still steps that limit treatment. Objective: Our aim in this study is to show whether sodium selenate (NaS), which has different effects on many different cells, has antiproliferative and apoptotic effects on MCF-7 breast cancer cells, considering the dose-time relationship, and to reveal its effect on oxidant stress parameters. Methods: 10, 20, 30, 40 and 50 μM sodium selenate was applied to the cells for 24, 48 and 72 hours. MTT test was applied to show the proliferative effect. Apoptosis was also measured with Annexin V/7AAD in MCF7 cells. Malondaldehyde (MDA) and Glutathione (GSH) levels were studied to reveal the oxidant/antioxidant balance. Results: It has been shown that as the NaS dose increases in MCF-7 cells, cell viability decreases (p 0.05), but at all subsequent increasing NaS doses, viability was found statistically significant decreased (p: 0.001, p 0.05, respectively). Conclusion: Considering that NaS has an antitumor effect on breast cancer, increases oxidative stress and increases apoptosis by supressing the antioxidant protection system, and does not have a toxic effect on normal body cells at certain doses. When all these features evaluated, we think, selenium should be considered as a natural option in the treatment of breast cancer.展开更多
文摘Introduction: Breast cancer is one of the most common types of cancer in the world and the treatments are being improved day by day. Although chemotherapy agents have begun to be used, side effects, resistance development and toxicity seen with these drugs are still steps that limit treatment. Objective: Our aim in this study is to show whether sodium selenate (NaS), which has different effects on many different cells, has antiproliferative and apoptotic effects on MCF-7 breast cancer cells, considering the dose-time relationship, and to reveal its effect on oxidant stress parameters. Methods: 10, 20, 30, 40 and 50 μM sodium selenate was applied to the cells for 24, 48 and 72 hours. MTT test was applied to show the proliferative effect. Apoptosis was also measured with Annexin V/7AAD in MCF7 cells. Malondaldehyde (MDA) and Glutathione (GSH) levels were studied to reveal the oxidant/antioxidant balance. Results: It has been shown that as the NaS dose increases in MCF-7 cells, cell viability decreases (p 0.05), but at all subsequent increasing NaS doses, viability was found statistically significant decreased (p: 0.001, p 0.05, respectively). Conclusion: Considering that NaS has an antitumor effect on breast cancer, increases oxidative stress and increases apoptosis by supressing the antioxidant protection system, and does not have a toxic effect on normal body cells at certain doses. When all these features evaluated, we think, selenium should be considered as a natural option in the treatment of breast cancer.
